NOVOSITE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, April 2, 2024, a trademark application was filed for NOVOSITE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOVOSITE THERAPEUTICS trademark a serial number of 98480811. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 2, 2024. This trademark is owned by Site TX, Inc.. The NOVOSITE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation
novosite therapeutics

General Information


Serial Number98480811
Word MarkNOVOSITE THERAPEUTICS
Filing DateTuesday, April 2, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSite TX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19904

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024NEW APPLICATION ENTERED
Sunday, September 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED